Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Eterna Therapeutics Inc. – Eterna Therapeutics |
Description | Rethinking INVESTOR RELATIONS Company Overview Executive Leadership Board of Directors Scientific Advisory Board Technology Overview Publications Pipeline Media Care |
Keywords | N/A |
WebSite | irxtherapeutics.com |
Host IP | 15.197.142.173 |
Location | United States |
Site | Rank |
US$1,005
Last updated: 2023-05-12 23:44:01
irxtherapeutics.com has Semrush global rank of 0. irxtherapeutics.com has an estimated worth of US$ 1,005, based on its estimated Ads revenue. irxtherapeutics.com receives approximately 116 unique visitors each day. Its web server is located in United States, with IP address 15.197.142.173. According to SiteAdvisor, irxtherapeutics.com is safe to visit. |
Purchase/Sale Value | US$1,005 |
Daily Ads Revenue | US$0 |
Monthly Ads Revenue | US$27 |
Yearly Ads Revenue | US$334 |
Daily Unique Visitors | 7 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
irxtherapeutics.com. | A | 599 | IP: 15.197.142.173 |
irxtherapeutics.com. | A | 599 | IP: 3.33.152.147 |
irxtherapeutics.com. | NS | 3600 | NS Record: pdns04.domaincontrol.com. |
irxtherapeutics.com. | NS | 3600 | NS Record: pdns03.domaincontrol.com. |
irxtherapeutics.com. | MX | 3600 | MX Record: 0 irxtherapeutics-com.mail.protection.outlook.com. |
irxtherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
INVESTOR RELATIONS Company Overview Executive Leadership Board of Directors Scientific Advisory Board Technology Overview Publications Pipeline Media Careers Contact Rethinking Biotherapeutics Our Vision We are unlocking the power of cell engineering to usher in the future of personalized, precision medicine. Our Technology Explore the tools that we use to rewrite cellular programs. Learn More Recent News May 04, 2023 Eterna Therapeutics to Deliver Eight Presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting May 02, 2023 Eterna Therapeutics Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeutics More News Privacy Policy Terms of Use © 2022 Eterna Therapeutics |
HTTP/1.1 405 Not Allowed Server: awselb/2.0 Date: Mon, 20 Dec 2021 06:28:33 GMT Content-Length: 0 Connection: keep-alive WAFRule: HTTPMethodNOTAllowed |
Domain Name: IRXTHERAPEUTICS.COM Registry Domain ID: 106949044_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-11-09T22:30:10Z Creation Date: 2003-11-19T20:21:49Z Registry Expiry Date: 2022-11-19T20:21:49Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: PDNS03.DOMAINCONTROL.COM Name Server: PDNS04.DOMAINCONTROL.COM DNSSEC: signedDelegation DNSSEC DS Data: 37147 13 2 F666D4BEF8346D8533D0AEBA681E33FBA7E31CF02CA3A68ECA31F29BA8DC5AF1 DNSSEC DS Data: 206 13 2 DB1C85D72D9D5475212E3FBE28B8C2A74FBBE0F3A3B81269A2A9376012178B22 >>> Last update of whois database: 2021-12-23T08:41:08Z <<< |